Mark S Sands
5PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 14, 2026
Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 Disease.Ewa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams
|Sep 04, 2025
Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets.Ewa A Ziółkowska, Keigo Takahashi, Patricia I Dickson
|Feb 20, 2025
Enteric nervous system degeneration in human and murine CLN3 disease, is ameliorated by gene therapy in mice.Ewa A Ziółkowska, Letitia L Williams, Matthew J Jansen
|Aug 26, 2020
Spinal manifestations of CLN1 disease start during the early postnatal period.H R Nelvagal, J T Dearborn, J R Ostergaard
|Mar 09, 2018
A HILIC-MS/MS method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum.Rohini Sidhu, Christina R Mikulka, Hideji Fujiwara
Pageof 1
Frequent Collaborators
4 joint publications
Jonathan D Cooper
3 joint publications
Ewa A Ziółkowska
2 joint publications
Alison K Snyder-Warwick
2 joint publications
Marco Sardiello
2 joint publications
Letitia L Williams
2 joint publications
Albina Jablonka-Shariff
1 joint publications
H R Nelvagal
1 joint publications
J T Dearborn
1 joint publications
Rohini Sidhu
1 joint publications
Christina R Mikulka
